InspireMD（納斯達克股票代碼：NSPR）公佈季度虧損$(6.45)每股，優於分析師一致預期的$(9.45)，提高了31.75%。這一數據相比去年同期每股虧損$(57.30)，增長了88.74%。公司報告季度銷售額爲$1.03百萬，超出分析師一致預期的$1.00百萬，提高了3.40%。與去年同期的$415.00千元銷售額相比，增長了149.16%。

以上內容來自Benzinga Earnings專欄，原文如下：

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(6.45) per share which beat the analyst consensus estimate of $(9.45) by 31.75 percent. This is a 88.74 percent increase over losses of $(57.30) per share from the same period last year. The company reported quarterly sales of $1.03 million which beat the analyst consensus estimate of $1.00 million by 3.40 percent. This is a 149.16 percent increase over sales of $415.00 thousand the same period last year.